From the Department of Ophthalmology, Marmara University Medical School, Istanbul, Turkey.
Cornea. 2010 Feb;29(2):133-40. doi: 10.1097/ICO.0b013e3181acf68d.
: To evaluate changes in mechanical sensitivity of cornea and conjunctiva in patients with dry eye disease unresponsive to artificial tears therapy and to investigate the effect of topical cyclosporine therapy on sensitivity of the ocular surface.
: Thirty-seven patients with dry eye disease and 35 healthy control subjects were enrolled to this prospective study. All patients included in the study completed a 3-month run-in period of using nonpreserved artificial tear supplements, but all failed to achieve adequate subjective or objective improvement. Patients were then instructed to use topical cyclosporine A 0.05% twice a day. Pre- and posttreatment (1, 3, and 6 months) evaluations included, corneal and conjunctival sensitivity testing with the Cochet-Bonnet esthesiometer, subjective symptom scoring, fluorescein and lissamine green staining, Schirmer test, and tear breakup time (BUT).
: Conjunctival and corneal sensitivities were significantly lower in patients with dry eye compared with controls (P < 0.0001). In patients with dry eye, corneal sensitivity correlated positively with conjunctival sensitivity and negatively with ocular surface staining scores. Conjunctival sensitivity correlated negatively with the duration of dry eye disease, the total symptom severity score, and the severity of dryness symptom and positively with Schirmer test and tear BUT. Corneal and conjunctival sensitivities did not change significantly after artificial tear therapy (P > 0.05). After topical cyclosporine, statistically significant improvements from baseline were observed in corneal sensitivity at 3- and 6-month visits (P < 0.001). For conjunctival sensitivity, statistically significant improvements from baseline were seen at all follow-up visits (P < 0.0001). Topical cyclosporine treatment also led to significant improvements in symptom scores, Schirmer test, tear BUT, and ocular surface staining scores (P < 0.0001).
: The mechanical sensitivity of cornea and conjunctiva to tactile stimulus is reduced in patients with dry eye. Our findings suggest that topical cyclosporine may be effective in improving this reduced mechanical sensitivity of the ocular surface.
评估人工泪液治疗反应不佳的干眼症患者角膜和结膜的机械敏感性变化,并研究局部环孢素治疗对眼表面敏感性的影响。
本前瞻性研究纳入 37 例干眼症患者和 35 例健康对照者。所有纳入研究的患者均完成了为期 3 个月的非防腐剂人工泪液补充剂使用预治疗期,但均未获得足够的主观或客观改善。随后,患者被指示使用局部环孢素 A 0.05%,每日 2 次。治疗前(1、3 和 6 个月)和治疗后评估包括:角膜和结膜感觉测试(Cochet-Bonnet 触觉计)、主观症状评分、荧光素和丽丝胺绿染色、泪液分泌试验(Schirmer 试验)和泪膜破裂时间(BUT)。
与对照组相比,干眼症患者的结膜和角膜敏感性明显降低(P < 0.0001)。在干眼症患者中,角膜敏感性与结膜敏感性呈正相关,与眼表面染色评分呈负相关。结膜敏感性与干眼症持续时间、总症状严重程度评分、干燥症状严重程度呈负相关,与 Schirmer 试验和泪液 BUT 呈正相关。人工泪液治疗后角膜和结膜敏感性无明显变化(P > 0.05)。局部环孢素治疗后,角膜敏感性在 3 个月和 6 个月随访时与基线相比有显著改善(P < 0.001)。对于结膜敏感性,所有随访时均与基线相比有显著改善(P < 0.0001)。局部环孢素治疗还导致症状评分、Schirmer 试验、泪液 BUT 和眼表面染色评分的显著改善(P < 0.0001)。
干眼症患者角膜和结膜对触觉刺激的机械敏感性降低。我们的研究结果表明,局部环孢素可能有效改善眼表面这种降低的机械敏感性。